Portfolio Lab

Biodexa Pharmaceuticals Plc

  • Stock
  • Ticker BDRX
  • ISIN US59564R8640
  • NASDAQ
  • US listing in dollars (ADR)

Performance, volatility and drawdowns of Biodexa Pharmaceuticals Plc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

1-year return
−98.8%
5-year return p.a.
−95.1%
10-year return p.a.
−85.8%
Volatility p.a.
139.9%
Largest decline
−100.0%

Performance

BDRXGlobal equities (VT)

$10,000 grew to $0. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −100.0% in 11/2026, measured from the peak in 02/2017. The old peak has not been reached again yet.

Annual returns

Best year 2021 at −43.9%, weakest 2023 at −96.6%. 0 of 9 full years were positive. * partial year.

Compared with Global equities

Since 11/2016BDRXGlobal equities (VT)
Return p.a.−85.8%+11.3%
Volatility p.a.139.9%15.1%
Largest decline−100.0%−34.2%
Return per unit of risk-0.610.74
$10,000 grew to$0$29,042

Bold: the better value in each row. Return per unit of risk: return p.a. divided by volatility p.a. Correlation of monthly returns with Global equities: 0.21 (1 would mean they moved in lockstep).

More stocks of similar size

Test BDRX in your own portfolio

Mix it with other securities, set recurring investments and costs, compare against a broad equity ETF. No account needed.

Open in backtest

Frequently asked questions

How has BDRX performed since 11/2016?

$10,000 grew to $0 by 20 Nov 2026, which is −85.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is BDRX?

Volatility was 139.9% per year, measured on monthly returns. The largest decline from a peak was −100.0%, with the low in 11/2026.

How does BDRX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, BDRX returned −85.8% at 139.9%. The correlation of monthly returns was 0.21; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's depositary receipt (ADR) traded in the US. On individual days its path differs slightly from the price on the home exchange.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.